article thumbnail

STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease

Med Page Today

(MedPage Today) -- CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building its positions in peripheral artery disease (PAD) and with an oral formulation, based on two major.

article thumbnail

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review

Cardiovascular Diabetology

Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). Individuals with T2DM exhibit a more severe manifes.

article thumbnail

Slowing of Peripheral Artery Disease: Another Liraglutide Benefit?

Med Page Today

(MedPage Today) -- Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes on subcutaneous liraglutide.

article thumbnail

Semaglutide and Walking Capacity in People With Symptomatic Peripheral Artery Disease and Type 2 Diabetes

American College of Cardiology

The goal of the phase 3b STRIDE trial was to evaluate the safety of once-weekly injections of the GLP-1 receptor agonist semaglutide and to determine whether it improves function (symptoms and quality of life [QoL]) in patients with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D) with functional limitations.

article thumbnail

How CTVS Treats Diabetes Complications

CTVS

Diabetes affects millions of Americans. If managed well through proper diet and medication, those with diabetes can lead full and active lives. There are however some serious complications commonly associated with diabetes, like cardiovascular disease, kidney disease, and PAD (Peripheral Artery Disease).

article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

article thumbnail

Role of long noncoding RNAs in diabetes-associated peripheral arterial disease

Cardiovascular Diabetology

Diabetes mellitus (DM) is a metabolic disease that heightens the risks of many vascular complications, including peripheral arterial disease (PAD). Various types of cells, including but not limited to endothel.